Bronchus

This is how tobacco damages our cells

Retrieved on: 
Friday, February 9, 2024

With the countless studies available today on the effects of tobacco use, we should have no trouble convincing ourselves and others of how harmful it is.

Key Points: 
  • With the countless studies available today on the effects of tobacco use, we should have no trouble convincing ourselves and others of how harmful it is.
  • The cells that make up our tissues, organs and body systems are sensitive to the effects of external toxic agents, many of which can be found in tobacco.
  • Many smokers not only accept this, but also ignore the serious danger it poses to the people around them.

Initial effects in the mouth and pharynx

  • When tobacco smoke enters our body, the first cells to receive it are in the mouth, nose and throat.
  • These effects on the immune system are also linked to a higher likelihood of developing cancer.
  • We also cannot forget that tobacco smoke robs us of our sense of taste and smell, leaving an almost continuous bitter taste in the mouth.

Lung damage

  • Furthermore, due to the direct damage caused by tobacco on the tissue that maintains the structure of the lungs, the bronchi and bronchioles become blocked, generating symptoms similar to suffocation.
  • As if that were not enough, people with COPD are also more likely to develop cardiovascular disease, and lung cancer.

Black tar and macrophages

  • We can cast our minds back to the previous image of my father’s pipe, black and sticky with tar.
  • It so happens that the lungs are rich in macrophages – special cells that play a key role in our immune systems by reacting to attacks, producing inflammatory responses.
  • These cells end up ingesting the tar from tobacco, and they eventually die loaded with this substance which builds up and gives a smoker’s lungs their characteristic blackened appearance.

Nicotine’s effects on neurons: dependence and addiction

  • As with any other compound that stimulates neurotransmitter receptors, permanent stimulation desensitises neurons.
  • This means that the neurons reduce the number of receptors, or change their sensitivity to the stimulant.
  • This desensitisation process can lead not only to nicotine dependence, but also to other diseases such as memory loss.


Guillermo López Lluch is a member of the Spanish Society of Cell Biology, the Spanish Society of Biochemistry and Molecular Biology, the Spanish Society of Geriatrics and Gerontology, the Society for Free Radical Research and the International Coenzyme Q10 Association. The research carried out by the author is financed by public funds from the Spanish Government or the Autonomous Government of Andalusia.

Broncus has announced the acquisition of the entire interest in Hangzhou Jingliang

Retrieved on: 
Friday, November 24, 2023

HANGZHOU, China, Nov. 23, 2023 /PRNewswire/ -- Broncus(2216.HK) is pleased to announce that, on November 23 2023 Broncus Hangzhou (a whollyowned subsidiary of Broncus, as Transferee) has entered into the Equity Transfer Agreement with the shareholders of the Hangzhou Jingliang, to acquire 100% equity interest in it.

Key Points: 
  • HANGZHOU, China, Nov. 23, 2023 /PRNewswire/ -- Broncus(2216.HK) is pleased to announce that, on November 23 2023 Broncus Hangzhou (a whollyowned subsidiary of Broncus, as Transferee) has entered into the Equity Transfer Agreement with the shareholders of the Hangzhou Jingliang, to acquire 100% equity interest in it.
  • It has addressed unmet clinical needs to a certain extent.
  • The advanced multimodal image automatic matching and integration technology of Broncus serves as the cornerstone for operations with flexible lung surgical robots.
  • The Target Company is a company specialized in the production and processing of medical devices and the development of software/hardware, and has the innovative manufacturing and intelligent production capabilities.

Finding a live brain worm is rare. 4 ways to protect yourself from more common parasites

Retrieved on: 
Tuesday, August 29, 2023

News reports this morning describe how shocked doctors removed a live worm from a woman’s brain in a Canberra hospital last year.

Key Points: 
  • News reports this morning describe how shocked doctors removed a live worm from a woman’s brain in a Canberra hospital last year.
  • In the case study published in Emerging Infectious Diseases journal, doctors describe removing the live 8cm-long nematode (roundworm) from the brain of the 64-year-old woman who was immunosuppressed.
  • The woman may have come into contact with worm eggs via snake faeces while foraging for Warrigal greens to eat.

Common parasites and how they get in

    • Giardia (Giardia duodenalis) is also very common and can contaminate food, water and surfaces.
    • This water-borne parasite is associated with poor sanitation and causes stomach symptoms like diarrhoea, cramps, bloating, nausea and fatigue.
    • Fortunately, these very common parasites do not infect the brain.
    • The parasites can remain in the body for years as tiny tissue cysts.
    • Read more:
      One in three people are infected with _Toxoplasma_ parasite – and the clue could be in our eyes

Then there are tapeworms and amoebas

    • Tapeworms can infect different parts of the body including the brain.
    • It is more likely in locations where pigs have contact with human faeces via sewerage or waterways.
    • Brain tissue can provide a home for larvae because it is soft and easy to get to via blood vessels.

Yikes! 4 ways to avoid parasitic infection

    • And we know being infected by a snake parasite is very rare – finding one alive in someone’s brain is even rarer.
    • To minimise your risk of infection you can: 1. avoid uncooked or raw pork.
    • Avoid pork if you are travelling in places with poor sanitation 2. avoid jumping or diving into warm fresh bodies of water, especially if they are known to carry Naegleria fowleri.

Electromed, Inc. Announces U.S. Food and Drug Administration 510(k) Clearance of Fifth Generation HFCWO Airway Clearance Generator

Retrieved on: 
Wednesday, November 30, 2022

Electromed, Inc. (NYSE American: ELMD) a leader in innovative airway clearance technologies, today announced that it received U.S Food and Drug Administration (FDA) 510(k) clearance of the SmartVest Clearway Airway Clearance System, which is designed for High Frequency Chest Wall Oscillation (HFCWO) therapy.

Key Points: 
  • Electromed, Inc. (NYSE American: ELMD) a leader in innovative airway clearance technologies, today announced that it received U.S Food and Drug Administration (FDA) 510(k) clearance of the SmartVest Clearway Airway Clearance System, which is designed for High Frequency Chest Wall Oscillation (HFCWO) therapy.
  • SmartVest Clearway meets these goals with its intuitive touch screen, the lightest weight generator on the market, and smaller footprint than our previous generation which continues our history of innovation in HFCWO therapy.
  • We are proud to further our mission and assist more patients to breathe easier and improve their quality of life.
  • The SmartVest Clearway Airway Clearance System is designed to deliver high frequency chest wall oscillation to promote airway clearance and improve bronchial drainage.

Global Bronchodilators Market Report to 2027 - Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, November 4, 2022

Bronchodilators are medications used to treat patients suffering from long-term conditions of narrow and inflamed airways, such as asthma, emphysema, and chronic obstructive pulmonary disease (COPD).

Key Points: 
  • Bronchodilators are medications used to treat patients suffering from long-term conditions of narrow and inflamed airways, such as asthma, emphysema, and chronic obstructive pulmonary disease (COPD).
  • They help relieve associated symptoms by relaxing the muscles around the airways or bronchi, clearing mucus from the lungs, and making breathing easier.
  • The publisher provides an analysis of the key trends in each sub-segment of the global bronchodilators market report, along with forecasts at the global, regional and country level from 2022-2027.
  • Our report has categorized the market based on indication, drug type and route of administration.

BRONCUS'S DISPOSABLE NEBULIZING MICRO-CATHETER FOR ENDOSCOPE WAS APPROVED FOR MARKETING IN CHINA AND ITS APPLICATIONS IN DRUG-DEVICE COMBINATION WILL BE BROADENED

Retrieved on: 
Monday, October 31, 2022

Currently, the Product is the only nebulizing micro-catheter product on the market which is approved and also protected by multiple patents in China.

Key Points: 
  • Currently, the Product is the only nebulizing micro-catheter product on the market which is approved and also protected by multiple patents in China.
  • Its application spans across multiple indications and can be compatible with a variety of drugs, broadening the application of drug-device combination in the field of lung disease treatment.
  • The drug distribution can be more uniform and the local drug concentration can be significantly increased, thereby directly enhancing the treatment effect.
  • The Company has been researching interventional pulmonary devices for years, and the Nebulizing Micro-catheter is the first achievement of the Company in the field of drug-device combination.

Ziosoft Highlights Virtual Surgical Visualization Solutions at Annual American College of Surgeons Conference

Retrieved on: 
Monday, October 17, 2022

SAN DIEGO, Oct. 17, 2022 /PRNewswire-PRWeb/ -- Ziosoft, a pioneer in 3D/4D AI medical visualization, will highlight its virtual surgical visualization solutions at the annual American College of Surgeons (ACS) conference being held October 16-20, 2022 in San Diego, California. The company will showcase software tools, such as lung and liver segmentation, to help enable efficient surgical planning analysis.

Key Points: 
  • SAN DIEGO, Oct. 17, 2022 /PRNewswire-PRWeb/ -- Ziosoft, a pioneer in 3D/4D AI medical visualization, will highlight its virtual surgical visualization solutions at the annual American College of Surgeons (ACS) conference being held October 16-20, 2022 in San Diego, California.
  • The company will showcase software tools, such as lung and liver segmentation, to help enable efficient surgical planning analysis.
  • "Ziosoft's segmentation analysis software provides extensive capabilities for surgical planning," said Rajeev Taitriya, vice president of marketing and business development for Ziosoft.
  • "These analytical tools assist surgeons to see and think in 3D, crossing the bridge between the gap of diagnostic readers to the operating table.

HEALIUM MEDICAL ENTERS INTO STRATEGIC COOPERATION AGREEMENT WITH BRONCUS HOLDING CORPORATION (2216.HK)

Retrieved on: 
Tuesday, September 13, 2022

YOKNEAM, Israel, Sept. 13, 2022 /PRNewswire/ -- Healium Medical ("Healium"), innovating a proprietary Dual-Mode Ultrasound Technology (DMUT) for the treatment of cardiac arrhythmias announced today a new collaboration and licensing agreement with Broncus Holding Corporation (2216.HK; "Broncus"). Broncus specializes in interventional diagnostic tools and treatments for pulmonary diseases by using ablation energy modalities including radiofrequency and thermal vapor. 

Key Points: 
  • YOKNEAM, Israel, Sept. 13, 2022 /PRNewswire/ -- Healium Medical ("Healium"), innovating a proprietary Dual-Mode Ultrasound Technology (DMUT) for the treatment of cardiac arrhythmias announced today a new collaboration and licensing agreement with Broncus Holding Corporation (2216.HK; "Broncus").
  • Broncus specializes in interventional diagnostic tools and treatments for pulmonary diseases by using ablation energy modalities including radiofrequency and thermal vapor.
  • Healium previously signed a licensing agreement in the cardiology space with Venus Medtech (2500.HK) to develop a therapeutic ultrasound technology for blood hypertension in 2021.
  • Healium Medical, a 12.75M EIC Accelerator 2021 Award recipient, is an innovative Israeli medical-device company part of Alon Medtech Ventures, owned by serial entrepreneur Dr.Shimon Eckhouse.

First Randomized Controlled Study with RejuvenAir® for Chronic Bronchitis shows Clinically Significant Results

Retrieved on: 
Tuesday, September 6, 2022

BOSTON, Sept. 6, 2022 /PRNewswire/ -- CSA Medical, Inc., today announced results from the first randomized, controlled study of Metered Cryospray (MCS) utilizing the RejuvenAir® System for the treatment of Chronic Bronchitis. The data was presented at the International Congress of the European Respiratory Society in Barcelona, Spain by Christopher Orton, MD, of The Royal Brompton Hospital, London, UK.

Key Points: 
  • RejuvenAir goes beyond medical management addressing the underlying cause of Chronic Bronchitis, damaged airways.
  • SGRQ and CAT, the gold standard measurement for patient reported symptom scores, were statistically significant and clinically meaningful, respectively.
  • "This first randomized controlled study data reinforces previous feasibility results showing Quality of Life improvement in patients with chronic bronchitis.
  • SPRAY-CB, thepivotal study of the RejuvenAir System in patients with COPD with Chronic Bronchitis, is actively enrolling.

Broncus (02216.HK) announced interim results

Retrieved on: 
Wednesday, August 31, 2022

HANGZHOU, China, Aug. 31, 2022 /PRNewswire/ -- On August 30, 2022, Broncus (02216.HK), the leader in the field of interventional pulmonology in China, reported its interim result for the six months ended June 30, 2022 (the "Reporting Period").

Key Points: 
  • Broncus has comprehensive pipelines in interventional diagnosis and treatment of lung diseases and leads the market of medical devices for pulmonary interventional.
  • Among them, Broncus have completed the First In Man clinical trial for Targeted Lung Denervation (TLD) Radiofrequency Ablation System.
  • In July 2022, Broncus have completed the product design and submit the type examination of InterVapor for Lung Cancer.
  • The core strength of Broncus can be further enhanced and more innovative technologies can be brought to patients with lung diseases all over the world.